Metabolic Reprogramming in HIV-Associated Neurocognitive Disorders
Copyright © 2022 Allen, Arjona, Santerre, De Lucia, Koch and Sawaya..
A significant number of patients infected with HIV-1 suffer from HIV-associated neurocognitive disorders (HAND) such as spatial memory impairments and learning disabilities (SMI-LD). SMI-LD is also observed in patients using combination antiretroviral therapy (cART). Our lab has demonstrated that the HIV-1 protein, gp120, promotes SMI-LD by altering mitochondrial functions and energy production. We have investigated cellular processes upstream of the mitochondrial functions and discovered that gp120 causes metabolic reprogramming. Effectively, the addition of gp120 protein to neuronal cells disrupted the glycolysis pathway at the pyruvate level. Looking for the players involved, we found that gp120 promotes increased expression of polypyrimidine tract binding protein 1 (PTBP1), causing the splicing of pyruvate kinase M (PKM) into PKM1 and PKM2. We have also shown that these events lead to the accumulation of advanced glycation end products (AGEs) and prevent the cleavage of pro-brain-derived neurotrophic factor (pro-BDNF) protein into mature brain-derived neurotrophic factor (BDNF). The accumulation of proBDNF results in signaling that increases the expression of the inducible cAMP early repressor (ICER) protein which then occupies the cAMP response element (CRE)-binding sites within the BDNF promoters II and IV, thus altering normal synaptic plasticity. We reversed these events by adding Tepp-46, which stabilizes the tetrameric form of PKM2. Therefore, we concluded that gp120 reprograms cellular metabolism, causing changes linked to disrupted memory in HIV-infected patients and that preventing the disruption of the metabolism presents a potential cure against HAND progression.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:16 |
---|---|
Enthalten in: |
Frontiers in cellular neuroscience - 16(2022) vom: 25., Seite 812887 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Allen, Charles N S [VerfasserIn] |
---|
Links: |
---|
Themen: |
Advanced glycation end-product |
---|
Anmerkungen: |
Date Revised 15.04.2022 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.3389/fncel.2022.812887 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM33948344X |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM33948344X | ||
003 | DE-627 | ||
005 | 20231226003010.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3389/fncel.2022.812887 |2 doi | |
028 | 5 | 2 | |a pubmed24n1131.xml |
035 | |a (DE-627)NLM33948344X | ||
035 | |a (NLM)35418836 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Allen, Charles N S |e verfasserin |4 aut | |
245 | 1 | 0 | |a Metabolic Reprogramming in HIV-Associated Neurocognitive Disorders |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 15.04.2022 | ||
500 | |a published: Electronic-eCollection | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a Copyright © 2022 Allen, Arjona, Santerre, De Lucia, Koch and Sawaya. | ||
520 | |a A significant number of patients infected with HIV-1 suffer from HIV-associated neurocognitive disorders (HAND) such as spatial memory impairments and learning disabilities (SMI-LD). SMI-LD is also observed in patients using combination antiretroviral therapy (cART). Our lab has demonstrated that the HIV-1 protein, gp120, promotes SMI-LD by altering mitochondrial functions and energy production. We have investigated cellular processes upstream of the mitochondrial functions and discovered that gp120 causes metabolic reprogramming. Effectively, the addition of gp120 protein to neuronal cells disrupted the glycolysis pathway at the pyruvate level. Looking for the players involved, we found that gp120 promotes increased expression of polypyrimidine tract binding protein 1 (PTBP1), causing the splicing of pyruvate kinase M (PKM) into PKM1 and PKM2. We have also shown that these events lead to the accumulation of advanced glycation end products (AGEs) and prevent the cleavage of pro-brain-derived neurotrophic factor (pro-BDNF) protein into mature brain-derived neurotrophic factor (BDNF). The accumulation of proBDNF results in signaling that increases the expression of the inducible cAMP early repressor (ICER) protein which then occupies the cAMP response element (CRE)-binding sites within the BDNF promoters II and IV, thus altering normal synaptic plasticity. We reversed these events by adding Tepp-46, which stabilizes the tetrameric form of PKM2. Therefore, we concluded that gp120 reprograms cellular metabolism, causing changes linked to disrupted memory in HIV-infected patients and that preventing the disruption of the metabolism presents a potential cure against HAND progression | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a HIV gp120 | |
650 | 4 | |a advanced glycation end-product | |
650 | 4 | |a glycolysis | |
650 | 4 | |a memory | |
650 | 4 | |a metabolic reprogramming | |
650 | 4 | |a neurons | |
700 | 1 | |a Arjona, Sterling P |e verfasserin |4 aut | |
700 | 1 | |a Santerre, Maryline |e verfasserin |4 aut | |
700 | 1 | |a De Lucia, Claudio |e verfasserin |4 aut | |
700 | 1 | |a Koch, Walter J |e verfasserin |4 aut | |
700 | 1 | |a Sawaya, Bassel E |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Frontiers in cellular neuroscience |d 2007 |g 16(2022) vom: 25., Seite 812887 |w (DE-627)NLM18392083X |x 1662-5102 |7 nnns |
773 | 1 | 8 | |g volume:16 |g year:2022 |g day:25 |g pages:812887 |
856 | 4 | 0 | |u http://dx.doi.org/10.3389/fncel.2022.812887 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 16 |j 2022 |b 25 |h 812887 |